ArticleJournal of cancer survivorship : research and practice2026
Longitudinal health-related quality of life profiles in esophageal cancer: insights from a nationwide prospective observational cohort study.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIdentifying patients with similar health-related quality of life (HRQoL) recovery patterns can guide more effective disease management. This study aimed to identify cross-sectional and longitudinal HRQoL profiles in esophageal cancer patients, and to examine associations with demographic and clinical characteristics.
methodsLongitudinal data from the Prospective Observational Cohort Study of Esophageal-gastric cancer Patients (POCOP) were analyzed. Patients treated with chemoradiation (CRT), with/without surgery, were followed for 12 months post-treatment. HRQoL was measured pre-treatment, at 6- and 12-months using validated questionnaires (i.e., EORTC QLQ-C30, QLQ-OG25, and HADS). Latent Profile and Latent Transition analyses were used to identify cross-sectional and longitudinal profiles, respectively. Regression analyses explored their associations with demographic and clinical characteristics.
resultsOf the 605 patients (mean age: 66.6 (SD: 8.0) years), most were male (82%) and had undergone surgery (73%). At each time point, two cross-sectional HRQoL profiles were identified: one with relatively high HRQoL (78-84%) and low HRQoL (16-22%). Both profiles showed significant impairments compared to population norms. Longitudinal analyses revealed five distinct HRQoL profiles: stable-high (65%), stable-low (5%), improving (10%), deteriorating (14%), and fluctuating (6%). Poorer HRQoL was associated with female sex and lower body mass index. Fluctuating HRQoL with surgery.
conclusionsIn our cohort, most esophageal cancer patients experienced relatively high or improving HRQoL, but some faced deteriorating or persistent impairments. Patients' sex, BMI, and surgery status may help identify those needing extra support. IMPLICATIONS FOR CANCER SURVIVORS: Recognizing different HRQoL profiles can help manage recovery expectations, and guide more personalized and timely care after treatment.
Indexed as
Identifiers
41555149What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.